Showing results (1001-1010 of 1,084) with videos related to

Sort By:
Pageof 109
Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patientsKerrie L McDonald, Maree G O'Sullivan, Jonathon F Parkinson, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2025
Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasitesEmma Y Mao, William Nguyen, Gouranga P Jana, et al.
ACS Chemical Biology|May 20, 2016
Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical ProteomicsGérard Joberty, Markus Boesche, Jack A Brown, et al.
The Journal of Biological Chemistry|October 27, 2016
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia CellsKavin Fatehchand, Elizabeth L McMichael, Brenda F Reader, et al.
ACS Infectious Diseases|December 12, 2018
Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of ActionMalkeet Kumar, John Okombo, Dickson Mambwe, et al.
Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.
Medical Physics|March 10, 2022
Advanced quantitative evaluation of PET systems using the ACR phantom and NiftyPET softwarePawel J Markiewicz, Casper da Costa-Luis, J Dickson, et al.
Pageof 109